LOS ANGELES (February 18, 2011) — Scientists at the Children’s Center for Cancer and Blood Diseases and The Saban Research Institute of Children’s Hospital Los Angeles today announced a breakthrough discovery in understanding how the body figh…
Oral administration of a drug that inhibits a process known as DNA methylation results in a reduction in the size of malignant tumors in mice, according to a team of researchers led by scientists from the Keck School of Medicine of the University of Southern California. The drug, called zebularine, accomplishes its tumor-whittling by turning on tumor suppressor genes that have been turned off by methylation.